• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透析依赖型终末期肾病患者血细胞参数与血管钙化关系的评估

Evaluation of the relationship between blood cell parameters and vascular calcification in dialysis-dependent end-stage renal disease patients.

作者信息

Chandra Abhilash, Raj Gaurav, Awasthi Namrata P, Rao Namrata, Srivastava Divya

机构信息

Department of Nephrology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

Department of Radiodiagnosis, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

出版信息

Saudi J Kidney Dis Transpl. 2020 Jan-Feb;31(1):136-143. doi: 10.4103/1319-2442.279933.

DOI:10.4103/1319-2442.279933
PMID:32129206
Abstract

Coronary artery calcification is an acceptable tool for cardiovascular risk assessment in end-stage renal disease (ESRD) population. We aimed to identify the association and predictive value of components of blood cell parameters with coronary and thoracic aorta vascular calcification (VC) in ESRD population on dialysis. All ESRD patients receiving hemodialysis or peritoneal dialysis aged between 18 and 60 years were included in the study. Exclusion criteria comprised patients with active infection or inflammatory disease, autoimmune disease, congestive heart failure, angina pectoris and/or documented coronary artery disease, thyroid disease, and hepatic dysfunction. Agatston scoring was used for the evaluation of coronary aorta calcification (CAC) score (CACS) and thoracic aorta calcification (TAC) score (TACS). Compared to participants with no VC, those who had VC were statistically significantly older (P <0.001) and had higher neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) (P = 0.02 and <0.001, respectively). On multivariate logistic regression analysis, increasing age (P = 0.00) and higher PLR (P = 0.04) were associated with an increased likelihood of exhibiting VC (CAC or TAC). There was a positive correlation between CACS and age (rs = 0.495, P = 0.00). A statistically significant positive correlation existed between TACS and age (rs = 0.516, P = 0.00). Similarly, a positive correlation was found between NLR, PLR, and TACS (rs = 0.334, P = 0.001, and rs = 0.438, P = 0.00, respectively). On multivariate linear regression analysis, increased age and red cell distribution width were found to be significant predictors of log(n) TACS. PLR of 135 gave a sensitivity of 80% and a specificity of 50% for predicting VC. Being a cost-effective and easily available investigation, the utilization of the correlation of NLR and PLR with CAC and TAC appears promising, particularly in the age group of 30-60 years.

摘要

冠状动脉钙化是终末期肾病(ESRD)人群心血管风险评估的一种可接受工具。我们旨在确定血细胞参数各组分与接受透析的ESRD人群冠状动脉和胸主动脉血管钙化(VC)之间的关联及预测价值。该研究纳入了所有年龄在18至60岁之间接受血液透析或腹膜透析的ESRD患者。排除标准包括患有活动性感染或炎症性疾病、自身免疫性疾病、充血性心力衰竭、心绞痛和/或有记录的冠状动脉疾病、甲状腺疾病以及肝功能不全的患者。采用阿加斯顿评分法评估冠状动脉钙化(CAC)评分(CACS)和胸主动脉钙化(TAC)评分(TACS)。与无VC的参与者相比,有VC的参与者在统计学上年龄显著更大(P<0.001),中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)更高(分别为P = 0.02和<0.001)。在多因素逻辑回归分析中,年龄增加(P = 0.00)和PLR升高(P = 0.04)与出现VC(CAC或TAC)的可能性增加相关。CACS与年龄呈正相关(rs = 0.495,P = 0.00)。TACS与年龄在统计学上存在显著正相关(rs = 0.516,P = 0.00)。同样,在NLR、PLR与TACS之间也发现了正相关(分别为rs = 0.334,P = 0.001和rs = 0.438,P = 0.00)。在多因素线性回归分析中,年龄增加和红细胞分布宽度被发现是log(n)TACS的显著预测因素。PLR为135时,预测VC的灵敏度为80%,特异度为50%。作为一种经济有效且易于获得的检查方法,NLR和PLR与CAC和TAC的相关性应用前景广阔,尤其是在30至60岁年龄组。

相似文献

1
Evaluation of the relationship between blood cell parameters and vascular calcification in dialysis-dependent end-stage renal disease patients.透析依赖型终末期肾病患者血细胞参数与血管钙化关系的评估
Saudi J Kidney Dis Transpl. 2020 Jan-Feb;31(1):136-143. doi: 10.4103/1319-2442.279933.
2
The relationship between neutrophil-to-lymphocyte ratio and vascular calcification in end-stage renal disease patients.终末期肾病患者中性粒细胞与淋巴细胞比值与血管钙化的关系。
Hemodial Int. 2014 Jan;18(1):47-53. doi: 10.1111/hdi.12065. Epub 2013 Jul 3.
3
Predictors of coronary calcification in Indian hemodialysis patients.印度血液透析患者冠状动脉钙化的预测因素
Saudi J Kidney Dis Transpl. 2018 Jul-Aug;29(4):822-827. doi: 10.4103/1319-2442.239643.
4
Coronary Artery Calcification in Hemodialysis and Peritoneal Dialysis.血液透析和腹膜透析中的冠状动脉钙化。
Am J Nephrol. 2018;48(5):369-377. doi: 10.1159/000494665. Epub 2018 Nov 13.
5
Progression of Vascular Calcification and Clinical Outcomes in Patients Receiving Maintenance Dialysis.维持性透析患者血管钙化的进展及临床转归。
JAMA Netw Open. 2023 May 1;6(5):e2310909. doi: 10.1001/jamanetworkopen.2023.10909.
6
Peri-aortic fat tissue and malnutrition-inflammation-atherosclerosis/calcification syndrome in end-stage renal disease patients.终末期肾病患者的腹主动脉周围脂肪组织与营养不良-炎症-动脉粥样硬化/钙化综合征。
Int Urol Nephrol. 2013 Jun;45(3):857-67. doi: 10.1007/s11255-012-0286-x. Epub 2012 Sep 23.
7
Vascular calcification in Mexican hemodialysis patients.墨西哥血液透析患者的血管钙化。
Arch Med Res. 2013 Nov;44(8):628-32. doi: 10.1016/j.arcmed.2013.10.018. Epub 2013 Nov 8.
8
Cardiovascular risk assessment and coronary artery calcification burden in asymptomatic patients in the initial years of hemodialysis.在开始血液透析的最初几年,对无症状患者进行心血管风险评估和冠状动脉钙化负担评估。
Ther Apher Dial. 2022 Feb;26(1):64-70. doi: 10.1111/1744-9987.13641. Epub 2021 Mar 31.
9
The relationship between coronary artery calcium scores and left atrium size in hemodialysis patients.血液透析患者冠状动脉钙化积分与左心房大小的关系。
Int Urol Nephrol. 2017 Sep;49(9):1661-1666. doi: 10.1007/s11255-017-1620-0. Epub 2017 May 18.
10
Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients.在终末期肾病患者中,血小板与淋巴细胞比值比中性粒细胞与淋巴细胞比值更能准确预测炎症反应。
Hemodial Int. 2013 Jul;17(3):391-6. doi: 10.1111/hdi.12040. Epub 2013 Mar 24.

引用本文的文献

1
Association of monocyte and lymphocyte ratio with risk of abdominal aortic calcification.单核细胞与淋巴细胞比值与腹主动脉钙化风险的关联。
PLoS One. 2025 Jul 3;20(7):e0327888. doi: 10.1371/journal.pone.0327888. eCollection 2025.
2
Progress in the application of novel inflammatory indicators in chronic kidney disease.新型炎症指标在慢性肾脏病中的应用进展
Front Med (Lausanne). 2025 Jan 30;12:1500166. doi: 10.3389/fmed.2025.1500166. eCollection 2025.
3
Clinical significance of neutrophil-to-lymphocyte ratio on the risk of abdominal aortic calcification and decreased bone mineral density in patients with end-stage kidney disease.
中性粒细胞与淋巴细胞比值对终末期肾病患者腹主动脉钙化和骨密度降低风险的临床意义。
PLoS One. 2023 Oct 25;18(10):e0286612. doi: 10.1371/journal.pone.0286612. eCollection 2023.
4
Progress in the application of the neutrophil-to-lymphocyte ratio in dialysis-related complications.中性粒细胞与淋巴细胞比值在透析相关并发症应用中的进展。
Ren Fail. 2023;45(2):2259996. doi: 10.1080/0886022X.2023.2259996. Epub 2023 Oct 4.
5
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: associations with mortality in a haemodialysis cohort.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值:与血液透析队列中死亡率的关联
Clin Kidney J. 2022 Nov 18;16(3):512-520. doi: 10.1093/ckj/sfac248. eCollection 2023 Mar.
6
Association of Red Blood Cell Distribution Width and Neutrophil-to-Lymphocyte Ratio with Calcification and Cardiovascular Markers in Chronic Kidney Disease.慢性肾脏病中红细胞分布宽度和中性粒细胞与淋巴细胞比值与钙化及心血管标志物的关联
Metabolites. 2023 Feb 17;13(2):303. doi: 10.3390/metabo13020303.
7
Association between fibrinogen/albumin ratio and severity of coronary artery calcification in patients with chronic kidney disease: a retrospective study.纤维蛋白原/白蛋白比值与慢性肾脏病患者冠状动脉钙化严重程度的关系:一项回顾性研究。
PeerJ. 2022 Jun 6;10:e13550. doi: 10.7717/peerj.13550. eCollection 2022.
8
Gender-Related Differences in Chronic Kidney Disease-Associated Vascular Calcification Risk and Potential Risk Mediators: A Scoping Review.慢性肾脏病相关血管钙化风险及潜在风险介导因素的性别差异:一项范围综述
Healthcare (Basel). 2021 Aug 1;9(8):979. doi: 10.3390/healthcare9080979.